142 related articles for article (PubMed ID: 8094983)
1. Changes of hepatic and systemic haemodynamics following somatostatin administration in patients with hepatitis B-related cirrhosis.
Hsia HC; Lin HC; Lee FY; Tsai YT; Lee SD; Meng HC; Chao Y; Wang SS; Lo KJ
J Gastroenterol Hepatol; 1993; 8(1):15-20. PubMed ID: 8094983
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic evaluation of octreotide in patients with hepatitis B-related cirrhosis.
Lin HC; Tsai YT; Lee FY; Lee SD; Hsia HC; Lin WJ; Lo KJ
Gastroenterology; 1992 Jul; 103(1):229-34. PubMed ID: 1612330
[TBL] [Abstract][Full Text] [Related]
3. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
Bosch J; Kravetz D; Rodes J
Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
[TBL] [Abstract][Full Text] [Related]
4. Effect of somatostatin on splanchnic hemodynamics in patients with liver cirrhosis and portal hypertension.
Merkel C; Gatta A; Zuin R; Finucci GF; Nosadini R; Ruol A
Digestion; 1985; 32(2):92-8. PubMed ID: 2864299
[TBL] [Abstract][Full Text] [Related]
5. Influence of somatostatin on splanchnic haemodynamics in patients with liver cirrhosis.
Eriksson LS; Law DH; Sato Y; Wahren J
Clin Physiol; 1984 Feb; 4(1):5-11. PubMed ID: 6141861
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic effects of a combination of octreotide and terlipressin in patients with viral hepatitis related cirrhosis.
Lin HC; Yang YY; Hou MC; Huang YT; Lee WC; Lee FY; Chang FY; Lee SD
Scand J Gastroenterol; 2002 Apr; 37(4):482-7. PubMed ID: 11989841
[TBL] [Abstract][Full Text] [Related]
7. Effects of terlipressin and somatostatin on liver and thorax blood volumes in patients with cirrhosis.
Kalambokis G; Tsiouris S; Tsianos EV; Baltayiannis G; Pakou B; Fotopoulos A
Liver Int; 2010 Oct; 30(9):1371-8. PubMed ID: 20738780
[TBL] [Abstract][Full Text] [Related]
8. Effect of octreotide on systemic, central, and splanchnic haemodynamics in cirrhosis.
Møller S; Brinch K; Henriksen JH; Becker U
J Hepatol; 1997 May; 26(5):1026-33. PubMed ID: 9186833
[TBL] [Abstract][Full Text] [Related]
9. Effects of somatostatin on hepatic haemodynamics in the cirrhotic rat.
Jenkins SA; Devitt P; Day DW; Baxter JN; Shields R
Digestion; 1986; 33(3):126-34. PubMed ID: 2868955
[TBL] [Abstract][Full Text] [Related]
10. [Effect of somatostatin on splanchnic hemodynamics in liver cirrhosis].
Merkel C; Gatta A; Zuin R; Finucci GF; Arnaboldi L; Ruol A
Minerva Med; 1984 Nov; 75(44):2673-8. PubMed ID: 6151151
[TBL] [Abstract][Full Text] [Related]
11. Systemic and regional hemodynamic effects of isosorbide dinitrate in patients with liver cirrhosis and portal hypertension.
Mols P; Hallemans R; Melot C; Lejeune P; Naeije R
J Hepatol; 1989 May; 8(3):316-24. PubMed ID: 2732445
[TBL] [Abstract][Full Text] [Related]
12. Effects of a somatostatin analogue SMS 201-995 on hepatic haemodynamics in the pig and on intravariceal pressure in man.
Jenkins SA; Baxter JN; Corbett WA; Shields R
Br J Surg; 1985 Dec; 72(12):1009-12. PubMed ID: 2867802
[TBL] [Abstract][Full Text] [Related]
13. Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: a double-blind hemodynamic investigation.
Cirera I; Feu F; Luca A; García-Pagán JC; Fernández M; Escorsell A; Bosch J; Rodés J
Hepatology; 1995 Jul; 22(1):106-11. PubMed ID: 7601400
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-1 contributes to maintenance of systemic but not portal haemodynamics in patients with early cirrhosis: a randomised controlled trial.
Tripathi D; Therapondos G; Ferguson JW; Newby DE; Webb DJ; Hayes PC
Gut; 2006 Sep; 55(9):1290-5. PubMed ID: 16434427
[TBL] [Abstract][Full Text] [Related]
15. [Effect of somatostatin on portal and hepatic hemodynamics and portal venous pressure in cirrhotic patients with portal hypertension].
Zhu J; Leng X; Feng H; Li S; Gan L; Zhang Y; Du R
Zhonghua Wai Ke Za Zhi; 1998 Jul; 36(7):433-5. PubMed ID: 11825434
[TBL] [Abstract][Full Text] [Related]
16. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.
Narahara Y; Kanazawa H; Taki Y; Kimura Y; Atsukawa M; Katakura T; Kidokoro H; Harimoto H; Fukuda T; Matsushita Y; Nakatsuka K; Sakamoto C
J Gastroenterol Hepatol; 2009 Nov; 24(11):1791-7. PubMed ID: 19686420
[TBL] [Abstract][Full Text] [Related]
17. Effects of isosorbide-5-mononitrate on variceal pressure and systemic and splanchnic haemodynamics in patients with cirrhosis.
Escorsell A; Feu F; Bordas JM; García-Pagán JC; Luca A; Bosch J; Rodés J
J Hepatol; 1996 Apr; 24(4):423-9. PubMed ID: 8738728
[TBL] [Abstract][Full Text] [Related]
18. Effect of somatostatin on splanchnic hemodynamics in patients with cirrhosis of the liver and in normal subjects.
Sonnenberg GE; Keller U; Perruchoud A; Burckhardt D; Gyr K
Gastroenterology; 1981 Mar; 80(3):526-32. PubMed ID: 6108898
[TBL] [Abstract][Full Text] [Related]
19. Effects of propranolol on hepatic haemodynamics in the cirrhotic and non-cirrhotic rat.
Jenkins SA; Baxter JN; Johnson JN; Devitt P; Shields R
Br J Surg; 1985 May; 72(5):354-8. PubMed ID: 3995241
[TBL] [Abstract][Full Text] [Related]
20. Nicardipine increases hepatic blood flow and the hepatic clearance of indocyanine green in patients with cirrhosis.
García-Pagán JC; Feu F; Luca A; Fernández M; Pizcueta P; Bosch J; Rodés J
J Hepatol; 1994 Jun; 20(6):792-6. PubMed ID: 7930480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
